Mastropolo Rosemarie, Cernik Colin, Uno Hajime, Fisher Lauren, Xu Lanfang, Laurent Cecile A, Cannizzaro Nancy, Munneke Julie, Cooper Robert M, Lakin Joshua R, Schwartz Corey M, Casperson Mallory, Altschuler Andrea, Kushi Lawrence, Chao Chun R, Wiener Lori, Mack Jennifer W
Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
JAMA Netw Open. 2024 Dec 2;7(12):e2450489. doi: 10.1001/jamanetworkopen.2024.50489.
Little is known about the nature of change in goals of care (GOC) over time among adolescents and younger adult (AYA) patients aged 12 to 39 years with cancer near the end of life. Understanding how GOC evolve may guide clinicians in supporting AYA patients in making end-of-life decisions.
To assess frequency, timing, and evolution of documented GOC among AYA patients with cancer in the last 90 days of life.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study included a retrospective review of medical records from the Dana-Farber Cancer Institute, Kaiser Permanente Northern California, and Kaiser Permanente Southern California of AYA patients with cancer who were 12 to 39 years of age at death and who died between January 1, 2003, and December 31, 2019. Data were analyzed from July 1, 2023, through April 30, 2024.
Stage IV cancer or stage I-III cancer with new metastasis or recurrence.
The primary outcome was documented GOC discussions, categorized by timing before death as initial (>60 days), middle (31-60 days), or late (≤30 days). Goals were classified as palliative, nonpalliative, undecided, or not discussed. Subgroup analysis according to race and ethnicity were also performed.
Among 1929 AYA patients with a mean (SD) age at cancer diagnosis of 28 (8) years, 1049 (54.5%) were female; 5 (0.3%) were American Indian or Alaska Native, 227 (11.8%) were Asian, 157 (8.1%) were Black or African American, 14 (0.7%) were Native Hawaiian or Other Pacific Islander, 1184 (61.4%) were White, 11 (0.6%) were of more than 1 race, 38 (2.0%) were categorized as other race, 293 (15.2%) were without documented race, 514 (26.6%) were Hispanic or Latino, 762 (39.5%) were not Hispanic or Latino, and 653 (33.9%) had no documented ethnicity. Few AYA patients had palliative goals documented in the initial period (139 [7.2%]), increasing to 331 (17.2%) in the middle period and 1113 (57.7%) in the late period. In total, 393 patients (20.4%) transitioned from documented nonpalliative goals in the initial or middle periods to palliative goals by the late period. Many patients had no documented GOC discussion until close to death (initial, 1364 [70.7%]; middle, 969 [50.2%]; and late, 322 [16.7%]). Among the 1929 patients, non-White patients were disproportionately represented among those not having documented GOC discussions (Black, 30 of 157 [19.1%]; Asian, 45 of 227 [19.8%]; and other or undocumented race, 80 of 361 [22.2%]) compared with White patients (167 of 1184 [14.1%]) (P < .001) as were Hispanic or Latino patients (116 of 514 [22.6%]) compared with non-Hispanic patients (93 of 762 [12.2%]) (P < .001) and individuals with no ethnicity documented (113 of 653 [17.3%]) (P < .001).
In this cross-sectional study of AYA patients who died of cancer, palliative goals were rarely documented before the last month of life, highlighting the need for timely and ongoing GOC discussions.
对于12至39岁临近生命末期的青少年及年轻成人(AYA)癌症患者,其临终关怀目标(GOC)随时间的变化性质了解甚少。了解GOC如何演变可能会指导临床医生支持AYA患者做出临终决策。
评估AYA癌症患者在生命最后90天内记录的GOC的频率、时间及演变情况。
设计、背景与参与者:这项横断面研究包括对达纳-法伯癌症研究所、北加利福尼亚凯撒医疗集团和南加利福尼亚凯撒医疗集团的医疗记录进行回顾性分析,研究对象为12至39岁死于癌症的AYA患者,这些患者于2003年1月1日至2019年12月31日期间死亡。数据于2023年7月1日至2024年4月30日进行分析。
IV期癌症或伴有新转移或复发的I - III期癌症。
主要结局是记录的GOC讨论,根据死亡前时间分为初始阶段(>60天)、中期(31 - 60天)或晚期(≤30天)。目标分为姑息性、非姑息性、未决定或未讨论。还进行了按种族和族裔的亚组分析。
在1929例癌症诊断时平均(标准差)年龄为28(8)岁的AYA患者中,1049例(54.5%)为女性;5例(0.3%)为美洲印第安人或阿拉斯加原住民,227例(11.8%)为亚洲人,157例(8.1%)为黑人或非裔美国人,14例(0.7%)为夏威夷原住民或其他太平洋岛民,1184例(61.4%)为白人,11例(0.6%)为多个种族,38例(2.0%)归类为其他种族,293例(15.2%)无种族记录,514例(26.6%)为西班牙裔或拉丁裔,762例(39.5%)非西班牙裔或拉丁裔,653例(33.9%)无族裔记录。很少有AYA患者在初始阶段记录有姑息性目标(139例[7.2%]),中期增至331例(17.2%),晚期增至1113例(57.7%)。共有393例患者(20.4%)从初始或中期记录的非姑息性目标转变为晚期的姑息性目标。许多患者直到临近死亡才记录有GOC讨论(初始阶段,1364例[70.7%];中期,969例[50.2%];晚期,322例[16.7%])。在1929例患者中,未记录GOC讨论的患者中,非白人患者比例过高(黑人,157例中的30例[19.1%];亚洲人,227例中的45例[19.8%];其他或无种族记录者,361例中的80例[22.2%]),而白人患者为1184例中的167例[14.1%](P <.001),西班牙裔或拉丁裔患者为514例中的116例[22.6%],而非西班牙裔患者为762例中的93例[12.2%](P <.001),无族裔记录者为653例中的113例[17.3%](P <.001)。
在这项对死于癌症的AYA患者的横断面研究中,临终前一个月之前很少记录有姑息性目标,这凸显了及时且持续进行GOC讨论的必要性。